P1.12-05 Combining Anti-HER3 Antibody, HMBD-001, with EGFR Inhibition and Chemotherapy may Improve Treatment Outcomes in SqNSCLC von Toy, W., Thakkar, D., Luu, K., Bui, N.L.C., Chau, K.F., Lai, J., Ray, D., Wu, S., Poi, M., Gandhi, N.A., Mas, A., Paszkiewicz, K., Ingram, P., Boyd-Kirkup, J.

Volltext